Call Us

    SAINT® Disclaimer: Look-Alike Programs Are Not SAINT®

    Written by Neuro Wellness TMS Centers of AmericaMedically reviewed by Daniel Pietras, MDPublished November 3, 2026Last medically reviewed November 3, 2026Last updated November 3, 2026

    Cognitive FX does not provide SAINT®. Its 5-day “fMRI-guided accelerated TMS” program is a different, off-label treatment, and Cognitive FX is not affiliated with SAINT®, Magnus Medical, Stanford University, or Neuro Wellness TMS Centers of America. SAINT’s published results — including 78.6% remission in the 2022 randomized controlled trial — come only from SAINT® and should not be expected from any look-alike program.

    Key takeaways

    • Cognitive FX does not provide SAINT®. Its 5-day “fMRI-guided accelerated TMS” program is a different treatment.
    • Cognitive FX states it is “not affiliated with, endorsed by or licensed by Stanford University or Magnus Medical” and “does not use Magnus Medical equipment or software.”
    • SAINT’s 78.6% remission result (Cole et al., 2022) comes only from SAINT® on the FDA-cleared Magnus system — not from any “alternative” or “fMRI-guided” program.
    • Copying SAINT’s 5-day schedule does not copy the FDA-cleared targeting the trials tested.
    • Neuro Wellness in Coral Springs, Florida is the verified SAINT® provider listed on Magnus Medical’s locator.

    The short version

    • Cognitive FX does not provide SAINT®. Its 5-day “fMRI-guided accelerated TMS” program is a different treatment.
    • There is no association between Cognitive FX and SAINT®, Magnus Medical, Stanford University, or Neuro Wellness TMS Centers of America. Cognitive FX states it is “not affiliated with, endorsed by or licensed by Stanford University or Magnus Medical” and “does not use Magnus Medical equipment or software.”
    • SAINT’s published results (including 78.6% remission in the 2022 randomized controlled trial) come only from SAINT®. They should not be expected from any other program, including one described as an “alternative”, “equivalent”, “fMRI-guided” or “accelerated”.
    • Being labeled an alternative to SAINT®, or mentioning fMRI, does not make a program SAINT® or make its results comparable.
    • To confirm a clinic offers real SAINT®, check Magnus Medical’s official provider locator: https://www.magnusmedical.com/find-a-provider

    Cognitive FX is not SAINT®, in its own words

    You don\u2019t have to take our word for it. Cognitive FX\u2019s own website says:

    • “Cognitive FX does not provide SAINT™” (source)
    • “our own protocol, delivered off-label” (source)
    • “rather than using Magnus Medical’s proprietary targeting system” (source)
    • “our protocol has not been tested in the SAINT clinical trials” (source)
    • “CFX’s program is an off-label equivalent of the SAINT protocol, not the licensed Magnus SAINT™ product” (source)
    • “Insurance Not billed” (source)
    • “Cognitive FX does not provide SAINT® and is not affiliated with, endorsed by or licensed by Stanford University or Magnus Medical.” (source)
    • “does not use Magnus Medical equipment or software” (source)

    Quotes accessed November 3, 2026. If Cognitive FX changes its wording, we will update this page.

    What “alternative”, “equivalent” and “fMRI-guided” do NOT mean

    “Alternative” or “equivalent”: A clinic calling its program an alternative or equivalent to SAINT\u00ae is a marketing description. It does not mean the program is SAINT\u00ae, is FDA-cleared as SAINT\u00ae, or produces SAINT\u2019s results.

    “fMRI-guided”: SAINT\u00ae is the only FDA-cleared system that uses an fMRI scan to personalize where TMS is aimed (FDA 510(k) K220177). Other programs that mention fMRI use their own targeting, which is not FDA-cleared for this purpose. Having an fMRI scan in the program does not make it SAINT\u00ae.

    Same schedule \u2260 same treatment: Copying SAINT\u2019s 5 days and session count does not copy the FDA-cleared targeting the trials tested. A program that was not studied in the SAINT trials can\u2019t claim the SAINT trials\u2019 results.

    Results disclaimer

    SAINT\u00ae response and remission rates published in peer-reviewed research (Cole et al., Am J Psychiatry 2022;179:132\u2013141) apply only to SAINT\u00ae delivered with the FDA-cleared Magnus Medical system under the SAINT protocol. They do not apply to, and should not be used to set expectations for, any off-label, look-alike, “fMRI-guided”, “accelerated” or “alternative” TMS program, including Cognitive FX\u2019s. Individual results with SAINT\u00ae also vary, and no outcome is guaranteed.

    Price disclaimer: the prices can’t be compared

    Cognitive FX publishes $9,900 for its 5-day program and states that travel and lodging are extra. That is the price of a different, off-label treatment, not a discounted SAINT\u00ae. SAINT\u00ae at Neuro Wellness starts at $25,000 for the full FDA-cleared course, has a Medicare payment rate, and may be approved by commercial insurance through prior authorization. We verify your benefits for free.

    See SAINT\u00ae TMS Cost and Cognitive FX vs SAINT\u00ae TMS.

    Our non-affiliation and trademark statement

    Neuro Wellness TMS Centers of America is a verified SAINT\u00ae provider listed on Magnus Medical\u2019s provider locator. We are not affiliated with, endorsed by, or connected to Cognitive FX. Cognitive FX is not affiliated with SAINT\u00ae, Stanford University or Magnus Medical: Cognitive FX\u2019s own website states it “does not provide SAINT\u00ae and is not affiliated with, endorsed by or licensed by Stanford University or Magnus Medical.” SAINT\u00ae is a registered trademark of Stanford University, exclusively licensed to Magnus Medical. Cognitive FX is named here only to identify the company and quote its public statements. This page is for patient education and is not medical advice.

    SAINT by Magnus Medical
    Watch & Learn

    Understanding SAINT® TMS: How It Works & What to Expect

    SAINT® is an FDA-cleared treatment for adults with major depressive disorder who have not improved on antidepressants in the current episode. These videos explain how it works and how it differs from conventional TMS.

    SAINT® is an FDA-cleared, fMRI-guided form of TMS developed at Stanford. Most patients complete treatment in one week — not the six weeks standard TMS requires.

    Follow a real patient through the five-day SAINT® treatment week

    Is SAINT® TMS Right for You?

    Tried antidepressants without enough relief? SAINT® TMS is an FDA-cleared, fMRI-guided treatment for adults with major depressive disorder who have not improved enough with antidepressant medication.

    SAINT® uses a personalized brain target and delivers treatment over five consecutive days. It differs from standard TMS in its targeting approach, treatment schedule, and research background. In a small randomized trial, 11 of 14 people receiving active treatment reached remission at the four-week assessment, compared with 2 of 15 receiving sham treatment. Results vary, and a five-day treatment course does not guarantee remission in five days.

    How SAINT® Works and How It Differs From Conventional TMS

    SAINT® is an FDA-cleared treatment for adults with major depressive disorder who have not improved on antidepressants in the current episode. This video explains how it works, and how it differs from conventional TMS.

    Conventional TMS usually means about 30 visits over 6 to 9 weeks. SAINT is five visits over five days.

    What makes it different: SAINT is the only FDA-cleared depression treatment that uses an fMRI scan to personalize the stimulation target to your individual brain. A 45-minute scan maps your brain and identifies the specific circuit linked to depression. Treatment is then delivered as ten 10-minute sessions per day, with 50-minute breaks between them, across five consecutive days.

    In clinical trials, 79% of participants reached remission, with an average of 2.6 days to remission. SAINT is generally well tolerated; the most common side effects reported were mild headache and temporary scalp discomfort at the treatment site.

    SAINT® at Neuro Wellness TMS Centers of America

    Coral Springs, Florida
    Free benefits check · Self-pay options available
    Call or Text: 954-827-9793

    Sources: Cole et al., American Journal of Psychiatry 2020;177:716-726 and 2022;179(2):132-141. magnusmedical.com/depression-therapy. PubMed 34711062. FDA 510(k) K220177.

    Insurance coverage for SAINT is currently limited and varies by plan. Individual results may vary. This video is educational and is not medical advice. Talk to a qualified clinician about whether SAINT is appropriate for you. If you are in crisis, call or text 988.

    Frequently Asked Questions

    Is Cognitive FX SAINT®?

    No. Cognitive FX’s own website says it does not provide SAINT™ and describes its program as its own protocol, delivered off-label, not tested in the SAINT clinical trials.

    Can I expect SAINT® results from Cognitive FX’s fMRI-guided TMS?

    No. SAINT’s published results come only from SAINT® on the FDA-cleared Magnus system, and Cognitive FX states its protocol was not tested in the SAINT trials, so those results don’t carry over.

    Is Cognitive FX affiliated with SAINT®, Stanford, Magnus Medical or Neuro Wellness?

    No. Cognitive FX has no association with SAINT®, Stanford University, Magnus Medical or Neuro Wellness; its own website states it is not affiliated with, endorsed by or licensed by Stanford or Magnus and does not use Magnus equipment or software.

    How do I know if a clinic offers real SAINT®?

    Check Magnus Medical’s official provider locator; in Florida, the verified provider is Neuro Wellness TMS Centers of America in Coral Springs.

    Important Safety Information

    Individual results vary. No outcome is guaranteed. Coverage varies by plan. SAINT® is contraindicated for people with non-removable magnetic-sensitive metal in or near the head, certain implanted devices, or increased intracranial pressure. Possible side effects include headache, fatigue, scalp discomfort and anxiety; TMS carries a small risk of seizure and, as with any depression treatment, a risk of worsening depression or suicidal thoughts. If you are in crisis, call or text 988.

    SAINT® is delivered only by verified providers on the Magnus Medical system. Programs described as SAINT “alternatives”, “equivalents” or “fMRI-guided accelerated TMS” are not SAINT®, are not affiliated with us, and SAINT® results do not apply to them. Read our SAINT® disclaimer.

    See if real SAINT® is a fit, free

    Speak with our clinical team. A free consultation is the best way to get answers specific to your situation.

    Cognitive FX is a trademark of its owner. SAINT® is a registered trademark of Stanford University, exclusively licensed to Magnus Medical, Inc. Neuro Wellness TMS Centers of America is a verified SAINT® provider and is not affiliated with, endorsed by, or connected to Cognitive FX. Quotes from Cognitive FX published materials were accessed November 3, 2026.